Publication | Closed Access
Epstein–Barr Virus in Inflammatory Bowel Disease—Correlation with Different Therapeutic Regimens
54
Citations
11
References
2013
Year
IBD is a risk factor for the presence of EBV DNA in blood, particularly in older patients and in those taking infliximab. C-reactive protein was not related to EBV DNA prevalence.
| Year | Citations | |
|---|---|---|
Page 1
Page 1